Comment on ‘KRAS-mutated plasma DNA as predictor of outcome from irinotecan monotherapy in metastatic colorectal cancer'

Detalles Bibliográficos
Autores principales: Tougeron, D, Laurent-Puig, P, Zaanan, A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4264418/
https://www.ncbi.nlm.nih.gov/pubmed/24619075
http://dx.doi.org/10.1038/bjc.2014.114
_version_ 1782348738737471488
author Tougeron, D
Laurent-Puig, P
Zaanan, A
author_facet Tougeron, D
Laurent-Puig, P
Zaanan, A
author_sort Tougeron, D
collection PubMed
description
format Online
Article
Text
id pubmed-4264418
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-42644182014-12-16 Comment on ‘KRAS-mutated plasma DNA as predictor of outcome from irinotecan monotherapy in metastatic colorectal cancer' Tougeron, D Laurent-Puig, P Zaanan, A Br J Cancer Letter to the Editor Nature Publishing Group 2014-12-09 2014-03-11 /pmc/articles/PMC4264418/ /pubmed/24619075 http://dx.doi.org/10.1038/bjc.2014.114 Text en Copyright © 2014 Cancer Research UK http://creativecommons.org/licenses/by-nc-sa/3.0/ This work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
spellingShingle Letter to the Editor
Tougeron, D
Laurent-Puig, P
Zaanan, A
Comment on ‘KRAS-mutated plasma DNA as predictor of outcome from irinotecan monotherapy in metastatic colorectal cancer'
title Comment on ‘KRAS-mutated plasma DNA as predictor of outcome from irinotecan monotherapy in metastatic colorectal cancer'
title_full Comment on ‘KRAS-mutated plasma DNA as predictor of outcome from irinotecan monotherapy in metastatic colorectal cancer'
title_fullStr Comment on ‘KRAS-mutated plasma DNA as predictor of outcome from irinotecan monotherapy in metastatic colorectal cancer'
title_full_unstemmed Comment on ‘KRAS-mutated plasma DNA as predictor of outcome from irinotecan monotherapy in metastatic colorectal cancer'
title_short Comment on ‘KRAS-mutated plasma DNA as predictor of outcome from irinotecan monotherapy in metastatic colorectal cancer'
title_sort comment on ‘kras-mutated plasma dna as predictor of outcome from irinotecan monotherapy in metastatic colorectal cancer'
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4264418/
https://www.ncbi.nlm.nih.gov/pubmed/24619075
http://dx.doi.org/10.1038/bjc.2014.114
work_keys_str_mv AT tougerond commentonkrasmutatedplasmadnaaspredictorofoutcomefromirinotecanmonotherapyinmetastaticcolorectalcancer
AT laurentpuigp commentonkrasmutatedplasmadnaaspredictorofoutcomefromirinotecanmonotherapyinmetastaticcolorectalcancer
AT zaanana commentonkrasmutatedplasmadnaaspredictorofoutcomefromirinotecanmonotherapyinmetastaticcolorectalcancer

Ejemplares similares